BUD13 and metabolic syndrome: BUD13, located in the APOC3/A4/A5 gene cluster on chromosome11q23.3 to be associated with serum lipid components (Lynn-Htet-Htet et al., 2014), ranked as the fifth most influential gene whose mutation contributed to MetS risk in the European population (rs10790162).